Generic lenalidomide for civahcs
Ended Awarded Last action
- Contract number
- 36C26326N0316
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $702,554
Award facts
- Contract value 47% obligated
-
- $702,554.44 Current, with exercised options
- $1,499,287.72 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order to Exelan Pharmaceuticals Inc. on January 1, 2026, for the supply of generic lenalidomide to the VA. The contract is a firm fixed-price delivery order with a ceiling value of approximately $1.5 million and an ultimate completion date of September 30, 2026. The work will be performed at Exelan's facility in Boca Raton, Florida. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), and no set-aside designation was applied to the procurement.
Exelan Pharmaceuticals Inc. is a foreign-owned pharmaceutical company specializing in the manufacturing, distribution, and repackaging of generic and branded pharmaceutical products for federal healthcare systems. The company maintains a strong track record supplying the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through multiple contract vehicles and indefinite delivery contracts with ceiling values ranging up to $88 million. Exelan's core competency in bulk drug repackaging and consolidation of pharmaceutical products into patient-ready prescriptions makes it well-suited to support the VA's critical healthcare delivery mission. The company maintains active registration in the System for Award Management and consistently competes in unrestricted, competitive procurements across federal agencies.
Quick answers
Who was awarded contract 36C26326N0316?
36C26326N0316 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on January 1, 2026.
How much is contract 36C26326N0316 worth?
The government has obligated $702,554 on 36C26326N0316. Its potential value, with all options, is $1,499,288.
Is contract 36C26326N0316 an order under another contract?
Yes. 36C26326N0316 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26326N0316 competed?
The extent of competition for 36C26326N0316 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award